IBDEI0M1 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10810,2)
 ;;=^269571
 ;;^UTILITY(U,$J,358.3,10811,0)
 ;;=443.9^^70^705^15
 ;;^UTILITY(U,$J,358.3,10811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10811,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,10811,1,4,0)
 ;;=4^PERIPH VASCULAR DIS
 ;;^UTILITY(U,$J,358.3,10811,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,10812,0)
 ;;=424.1^^70^705^3
 ;;^UTILITY(U,$J,358.3,10812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10812,1,3,0)
 ;;=3^424.1
 ;;^UTILITY(U,$J,358.3,10812,1,4,0)
 ;;=4^AORTIC VALVE DIS
 ;;^UTILITY(U,$J,358.3,10812,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,10813,0)
 ;;=459.81^^70^705^16
 ;;^UTILITY(U,$J,358.3,10813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10813,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,10813,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY
 ;;^UTILITY(U,$J,358.3,10813,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,10814,0)
 ;;=411.1^^70^705^2
 ;;^UTILITY(U,$J,358.3,10814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10814,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,10814,1,4,0)
 ;;=4^ANGINA PECTORIS/UNSTABLE
 ;;^UTILITY(U,$J,358.3,10814,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,10815,0)
 ;;=429.2^^70^705^4
 ;;^UTILITY(U,$J,358.3,10815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10815,1,3,0)
 ;;=3^429.2
 ;;^UTILITY(U,$J,358.3,10815,1,4,0)
 ;;=4^ASCVD
 ;;^UTILITY(U,$J,358.3,10815,2)
 ;;=^19738
 ;;^UTILITY(U,$J,358.3,10816,0)
 ;;=414.01^^70^705^6
 ;;^UTILITY(U,$J,358.3,10816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10816,1,3,0)
 ;;=3^414.01
 ;;^UTILITY(U,$J,358.3,10816,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,10816,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,10817,0)
 ;;=401.9^^70^705^10
 ;;^UTILITY(U,$J,358.3,10817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10817,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,10817,1,4,0)
 ;;=4^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,10817,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,10818,0)
 ;;=394.0^^70^705^13
 ;;^UTILITY(U,$J,358.3,10818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10818,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,10818,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,10818,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,10819,0)
 ;;=796.3^^70^705^12
 ;;^UTILITY(U,$J,358.3,10819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10819,1,3,0)
 ;;=3^796.3
 ;;^UTILITY(U,$J,358.3,10819,1,4,0)
 ;;=4^LOW BLOOD PRESSURE READING
 ;;^UTILITY(U,$J,358.3,10819,2)
 ;;=^273465
 ;;^UTILITY(U,$J,358.3,10820,0)
 ;;=796.2^^70^705^9
 ;;^UTILITY(U,$J,358.3,10820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10820,1,3,0)
 ;;=3^796.2
 ;;^UTILITY(U,$J,358.3,10820,1,4,0)
 ;;=4^ELEVATED B/P w/o HTN
 ;;^UTILITY(U,$J,358.3,10820,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,10821,0)
 ;;=285.9^^70^706^1
 ;;^UTILITY(U,$J,358.3,10821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10821,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,10821,1,4,0)
 ;;=4^ANEMIA
 ;;^UTILITY(U,$J,358.3,10821,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,10822,0)
 ;;=266.2^^70^706^2
 ;;^UTILITY(U,$J,358.3,10822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10822,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,10822,1,4,0)
 ;;=4^B12 & FOLATE ANEMIA
 ;;^UTILITY(U,$J,358.3,10822,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,10823,0)
 ;;=272.0^^70^706^3
 ;;^UTILITY(U,$J,358.3,10823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10823,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,10823,1,4,0)
 ;;=4^CHOLESTEROL (HYPER)
 ;;^UTILITY(U,$J,358.3,10823,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,10824,0)
 ;;=250.00^^70^706^6
 ;;^UTILITY(U,$J,358.3,10824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10824,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,10824,1,4,0)
 ;;=4^DIABETES MEL W/O COMP, TYPE II
